Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-23-016460

SVP, Business Development sold 16,777 shares at an average $6.23 ($104,584)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Birznieks Gunther SVP, Business Development 2023-03-02 Sale −8,509 $6.20 $52,793 214,248 D
Birznieks Gunther SVP, Business Development 2023-03-03 Sale −8,268 $6.26 $51,791 205,980 D
Open-market sales · 16,777 sh · avg $6.23 · $104,584
Loading xslF345X03/doc4.xml…